Drug intelligence / Profile preview

testosterone mix

Development stage
Unknown
Lead developer
Organon
Modality
Small Molecules
Administration
Intramuscular
01

Overview

SUSTA DS is an injectable testosterone ester mixture developed and manufactured by March Pharma. It is a small molecule formulation designed to provide a rapid onset of action followed by a sustained release of testosterone into the systemic circulation. The product typically contains a blend of four testosterone esters: testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, and testosterone decanoate. As an androgen receptor agonist, SUSTA DS is primarily indicated for testosterone replacement therapy in males with conditions associated with primary and secondary hypogonadism. By binding to and activating intracellular androgen receptors, it promotes the development and maintenance of male sexual characteristics, increases muscle mass, and improves bone mineral density. The 'DS' designation often refers to a higher concentration or 'Double Strength' formulation compared to standard testosterone mix products.

Brand names
SUSTA DS
Other names
Testosterone estersTestosterone compoundTestosterone mixture
02

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on testosterone mix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on testosterone mix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call